Kronos Bio, Inc. ( KRON) - Key Metrics
Stock symbol KRON is outdated, potentially delisted? Maybe it is available on other exchange?
KRON Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $0.03 | -$0.14 | -$0.21 | -$0.21 |
| 2024Q4 | $0.04 | -$0.43 | -$0.21 | -$0.21 |
| 2024Q3 | $0.04 | -$0.23 | -$0.21 | -$0.21 |
| 2024Q2 | $0.04 | -$0.27 | -$0.27 | -$0.27 |
| 2024Q1 | $0.04 | -$0.50 | -$0.40 | -$0.40 |
KRON Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -1.50 |
| 2024Q4 | ? | -0.56 |
| 2024Q3 | ? | -1.07 |
| 2024Q2 | ? | -1.04 |
| 2024Q1 | ? | -0.69 |
KRON
Price: $0.88
52 week price:
Earnings Per Share: -1.07 USD
P/E Ratio: -0.64
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 184700
Market Capitalization: 41.5 million